DPH — Dechra Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Dechra Pharmaceuticals, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	227	118	121	74.4	82.9
Net Total Accounts Receivable
Net Total Receivables	97.3	119	142	170	465
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	449	392	444	468	569
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	76.4	87	100	159	1.69
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,238	1,214	1,293	1,569	1,492
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	137	156	159	164	216
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	600	581	627	814	721
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	638	633	667	755	771
Total Liabilities & Shareholders' Equity	1,238	1,214	1,293	1,569	1,492
Total Common Shares Outstanding